Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Baron, M.H"'
Autor:
Remonnay, R., Morelle, M., Pommier, P., Haie-Meder, C., Quetin, P., Kerr, C., Delannes, M., Castelain, B., Peignaux, K., Kirova, Y., Romestaing, P., Williaume, D., Krzisch, C., Thomas, L., Lang, P., Baron, M.H., Cussac, A., Lesaunier, F., Maillard, S., Barillot, I., Charra-Brunaud, C., Carrère, M.-O., Peiffert, D.
Publikováno v:
In Cancer / Radiothérapie 2010 14(3):161-168
Autor:
Boer, S.M. de, Powell, M.E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P.B., Ledermann, J.A., Khaw, P., Colombo, A., Fyles, A., Baron, M.H., Jurgenliemk-Schulz, I.M., Kitchener, H.C., Nijman, H.W., Wilson, G., Brooks, S., Carinelli, S., Provencher, D., Hanzen, C., Lutgens, L.C.H.W., Smit, V.T.H.B.M., Singh, N., V. do, D'Amico, R., Nout, R.A., Feeney, A., Verhoeven-Adema, K.W., Putter, H., Creutzberg, C.L., PORTEC Study Grp
Publikováno v:
Lancet Oncology, 19(3), 295-309. ELSEVIER SCIENCE INC
The Lancet Oncology, 19(3), 295-309
Lancet Oncology, 19, 3, pp. 295-309
Lancet oncology, 19(3), 295-309. Elsevier Science
Lancet Oncology, 19, 295-309
The Lancet Oncology, 19(3), 295-309
Lancet Oncology, 19, 3, pp. 295-309
Lancet oncology, 19(3), 295-309. Elsevier Science
Lancet Oncology, 19, 295-309
Background Although women with endometrial cancer generally have a favourable prognosis, those with high-risk disease features are at increased risk of recurrence. The PORTEC-3 trial was initiated to investigate the benefit of adjuvant chemotherapy d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::11bd42e0bdc9d24ffed3f32e687ad960
https://doi.org/10.1016/s1470-2045(18)30079-2
https://doi.org/10.1016/s1470-2045(18)30079-2
Publikováno v:
In BBA - General Subjects 2005 1724(3):367-374
Publikováno v:
In Journal of Colloid And Interface Science 2004 273(2):414-425
Autor:
Boer, S.M. de, Powell, M.E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P.B., Ledermann, J.A., Khaw, P., Colombo, A., Fyles, A., Baron, M.H., Kitchener, H.C., Nijman, H.W., Kruitwagen, R.F., Nout, R.A., Verhoeven-Adema, K.W., Smit, V.T., Putter, H., Creutzberg, C.L., PORTEC Study Grp
Publikováno v:
Lancet oncology, 17(8), 1114-1126. Elsevier Science
The Lancet. Oncology
Lancet Oncology, 17, 8, pp. 1114-26
Lancet Oncology, 17(8), 1114-1126. ELSEVIER SCIENCE INC
The Lancet Oncology, 17(8), 1114-1126
Lancet Oncology, 17, 1114-26
The Lancet. Oncology
Lancet Oncology, 17, 8, pp. 1114-26
Lancet Oncology, 17(8), 1114-1126. ELSEVIER SCIENCE INC
The Lancet Oncology, 17(8), 1114-1126
Lancet Oncology, 17, 1114-26
Contains fulltext : 171831.pdf (Publisher’s version ) (Open Access) BACKGROUND: About 15% of patients with endometrial cancer have high-risk features and are at increased risk of distant metastases and endometrial cancer-related death. We designed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1712cbb2b9a7b0f1b67716842226d32a
Autor:
Lorchel, F., Bosset, J.F. *, Bartholomot, B., Baron, M.H., Mantion, G., Pelissier, E.P., Goubard, O., Maingon, P.
Publikováno v:
In Cancer / Radiothérapie 2001 5(5):542-549
Publikováno v:
In Journal of Colloid And Interface Science 15 June 1999 214(2):319-332
Autor:
Creutzberg, C.L., Boer, S.M. de, Putter, H., Powell, M., Mileshkin, L.R., Katsaros, D., Bessette, P., Haie-Meder, C., Ledermann, J.A., Ottevanger, P.B., Khaw, P., Colombo, A., Fyles, A.W., Baron, M.H., Nijman, H.W., Nout, R.A., Smit, V.T.H.B.M., Verhoeven-Adema, K., Kruitwagen, R.F.P.M., Kitchener, H.C.
Publikováno v:
Journal of Clinical Oncology, 33(15)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::88347b1bf6a5d1ad869dd420d2d38193
https://hdl.handle.net/1887/100248
https://hdl.handle.net/1887/100248
Autor:
Capelle, L., Taillandier, L., Peruzzi, P., Bauchet, L., Fontaine, D., Baron, M.H., Kherli, P., Jouanneau, E., Guyotat, J., Mandonnet, E., Duffau, H.
Publikováno v:
In Neurochirurgie 2004 50(5):573-573
Autor:
De Boer, S.M., Powell, M.E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P.B., Ledermann, J.A., Khaw, P., Colombo, A., Fyles, A., Baron, M.H., Jürgenliemk-Schulz, I.M., Kitchener, H.C., Nijman, H.W., Wilson, G., Kolodziej, I., Carinelli, S., Lutgens, L.C.H.W., Smit, V.T.H.B.M., Singh, N., Nout, R.A., Verhoeven-Adema, K.W., Putter, H., Creutzberg, C.L.
Publikováno v:
In Radiotherapy and Oncology April 2018 127 Supplement 1:S171-S172